🇺🇸 FDA
Pipeline program

PACLITAXEL, Cyramza 10 mg/ml concentrate for solution for infusion, DS-8201a, Cyramza 10 mg/ml concentrate for solution for infusion, Cyramza 10 mg/ml concentrate for solution for infusion

DS8201-A-U306

Phase 3 small_molecule active

Quick answer

PACLITAXEL, Cyramza 10 mg/ml concentrate for solution for infusion, DS-8201a, Cyramza 10 mg/ml concentrate for solution for infusion, Cyramza 10 mg/ml concentrate for solution for infusion for Metastatic Gastric Adenocarcinoma is a Phase 3 program (small_molecule) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Daiichi Sankyo Europe GmbH
Indication
Metastatic Gastric Adenocarcinoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials